| Kresta, Schnider & Partners AG |
| Landesbank Baden-Württemberg |
| Light Sciences Oncology, Inc. |
| LSP |
| MC Services |
| MD Becker Partners |
| Med Discovery |
| MEDC PARTNERS |
| Medicyte |
| MedNous |
| MedVenture Partners GmbH |
| Mellitech |
| Merck & Co. |
| Merck Serono International S.A. |
| Merck Serono Ventures |
| Mergermarket |
| MetrioPharm |
| Molcode |
| Molecular Partners AG |
| MolMed S.p.A |
| mondoBIOTECH |
| MorphoSys AG |
| Motif BioSciences Inc |
| Mucosis B.V |
| Mummert & Company Corporate Finance GmbH |
| NeurAxon Inc |
| Nextech Ventures |
| Nexus Medical Pharma |
| NGN Capital LLC |
| Nomura Code Securities |
| Novartis International AG |
| Novartis Venture Fund |
| Noventia Pharma |
| NovImmune SA |
| Novo A/S |
| Novo Growth Equity |
| Novo Nordisk A/S |
| Nuon Therapeutics, Inc. |
| Nycomed |
| NYSE Euronext |
| OCT Group LLC |
| OncoMethylome Sciences S.A. |
| Orexo AB |
| Oryzon |
| Osprey Capital Partners |
| Oxford University, Nuffield Department of Clinical Medicine |
| Oxygen Biotherapeutics |
| Palatin Technologies |
| Patrys Ltd |
| Paul Capital |
| Pantec Biosolutions AG |
| PDS Biotechnology Corporation |
| Pergamum |
| Pernet Portfolio Management |
| Pevion Biotech |
| Pfizer, Inc. |
| PharmaVentures Ltd |
| PharmaWave Ltd |
| Pharmawire |
| PolyMedix Inc. |
| Priaxon AG |
| PricewaterhouseCoopers |
| Privateq Advisors |
| Proximagen Neuroscience |
| Quest Management NV |
| Redbiotech |
| Remaco Corporate Finance |
| Renessens GmbH |
| Repregen |
| Response Biomedical |
| Reuters |
| Roche Partnering |
| Roche Venture Fund |
| SE Swiss Equities |
| Sal. Oppenheim Jr. & Cie |
| Scancell Limited |
| Scil Proteins GmbH |
| SCYNEXIS, Inc. |
| Sectoral Asset Management |
| Sensimed AG |
| Sirius Healthcare Partners GmbH |
| SIX Swiss Exchange AG |
| Sherbrook Capital Management |
| Signature Diagnostocs AG |
| Silence Therapeutics AG |
| S.M.R. Interimsmanagement and Consulting |
| Sorg Consulting |
| Stemergie Biotechnology SA |
| Stratos Bio |
| Sunstone Capital A/S |
| SVB Silicon Valley bank |
| Swiss Biotech Association |
| Swiss Equity Medien |
| Syndax Pharmaceuticals, Inc. |
| Syntaxin Ltd |
| Takeda Research Investment, Inc. |
| TBA |
| tecnet capital Technologiemanagement GmbH |
| Tech Investor |
| Technology Consulting |
| Telormedix |
| The Channel Group |
| The Corporate Development Company |
| Thuja Capital |
| Tiburon Bio Consulting |
| Tigenix |
| ToBBB Technology |
| TopoTarget |
| Trigon Medical |
| Trout International, LLC |
| Tudor Reilly |
| TxCell |
| UCB Pharma |
| University of Tuebingen |
| Ventech |
| Venture Partners AG |
| Venture Valuation AG |
| Vesalius Biocapital |
| VI Partners AG |
| ViroLogiK GmbH |
| Vontobel Investment Bank |
| Warburg Pincus LLC |
| Warwick Effect Polymers Ltd |
| Wellington Partners |
| Wenzel Healthcare Services |
| Werder Consulting |
| Widmann Associates |
| WITA Proteomics AG |
| Xention Ltd. |
| Zürcher Kantonalbank |
|
|